Chris LeMasters
2018
In 2018, Chris LeMasters earned a total compensation of $1.9M as Executive Vice President and Chief Business Officer at Mirati Therapeutics, a 285% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $217,800 |
|---|---|
| Option Awards | $1,353,082 |
| Salary | $363,000 |
| Other | $2,500 |
| Total | $1,936,382 |
LeMasters received $1.4M in option awards, accounting for 70% of the total pay in 2018.
LeMasters also received $217.8K in non-equity incentive plan, $363K in salary and $2.5K in other compensation.
Rankings
In 2018, Chris LeMasters' compensation ranked 5,917th out of 14,244 executives tracked by ExecPay. In other words, LeMasters earned more than 58.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,917 out of 14,244 | 59th |
Division Manufacturing | 2,250 out of 5,759 | 61st |
Major group Chemicals And Allied Products | 839 out of 2,122 | 61st |
Industry group Drugs | 701 out of 1,811 | 61st |
Industry Pharmaceutical Preparations | 545 out of 1,385 | 61st |
Source: SEC filing on April 19, 2019.
LeMasters' colleagues
We found four more compensation records of executives who worked with Chris LeMasters at Mirati Therapeutics in 2018.